Clinical trial
Caffeine for Apnea of Prematurity (CAP)
NCT00182312 · McMaster University, Other · Completed
Key facts
| NCT number | NCT00182312 |
|---|---|
| Title | Caffeine for Apnea of Prematurity (CAP) |
| Official title | Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants |
| Lead sponsor | McMaster University, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) National Health and Medical Research Council, Australia |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Apnea of Prematurity |
| Intervention type | Drug |
| Interventions | Caffeine citrate injection |
| Enrollment | 2,000 |
| Start date | Oct 1, 1999 |
| Primary completion | Mar 1, 2007 |
| Completion | Jul 1, 2016 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 22, 2018 |
| Countries | Australia, Canada, Germany, Israel, Netherlands, Sweden, Switzerland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: